BISCAGLIA, Simone
 Distribuzione geografica
Continente #
NA - Nord America 5.591
EU - Europa 1.726
AS - Asia 1.536
SA - Sud America 147
OC - Oceania 28
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.051
Nazione #
US - Stati Uniti d'America 5.546
CN - Cina 593
SG - Singapore 445
DE - Germania 360
IT - Italia 354
FI - Finlandia 183
GB - Regno Unito 173
TR - Turchia 166
PL - Polonia 136
BR - Brasile 131
UA - Ucraina 128
FR - Francia 122
SE - Svezia 118
ID - Indonesia 103
CA - Canada 39
HK - Hong Kong 38
BE - Belgio 36
IN - India 35
VN - Vietnam 34
AU - Australia 27
KR - Corea 26
JP - Giappone 16
NL - Olanda 16
EG - Egitto 14
LT - Lituania 14
RU - Federazione Russa 13
AT - Austria 12
CZ - Repubblica Ceca 12
IR - Iran 11
MY - Malesia 11
ES - Italia 9
PK - Pakistan 8
TH - Thailandia 8
AR - Argentina 6
PT - Portogallo 6
TW - Taiwan 6
CY - Cipro 5
IQ - Iraq 5
CH - Svizzera 4
IL - Israele 4
MX - Messico 4
AE - Emirati Arabi Uniti 3
CO - Colombia 3
DK - Danimarca 3
IE - Irlanda 3
KE - Kenya 3
LI - Liechtenstein 3
RO - Romania 3
BD - Bangladesh 2
BY - Bielorussia 2
CL - Cile 2
EC - Ecuador 2
EU - Europa 2
HR - Croazia 2
HU - Ungheria 2
LV - Lettonia 2
MK - Macedonia 2
NO - Norvegia 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AL - Albania 1
AZ - Azerbaigian 1
ET - Etiopia 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
SI - Slovenia 1
TM - Turkmenistan 1
TN - Tunisia 1
VE - Venezuela 1
Totale 9.051
Città #
Fairfield 754
Woodbridge 562
Ashburn 469
Houston 418
Santa Clara 414
Chandler 331
Singapore 331
Seattle 303
Ann Arbor 298
Wilmington 288
Cambridge 265
Munich 186
Jacksonville 181
Helsinki 149
Beijing 134
Warsaw 131
Izmir 93
Princeton 93
New York 88
Shanghai 88
Nanjing 82
Jakarta 78
Ferrara 69
Milan 66
San Diego 62
Los Angeles 45
London 39
Brussels 36
Boardman 30
Bremen 28
Falls Church 28
Nanchang 22
Frankfurt am Main 20
Hong Kong 20
Redwood City 19
Nuremberg 18
Shenyang 17
Toronto 17
Bologna 16
Norwalk 16
Tianjin 16
Dong Ket 15
Jiaxing 15
Melbourne 15
Changsha 14
Chicago 14
Hebei 14
Des Moines 13
Mumbai 13
Ottawa 13
Washington 13
Falkenstein 12
Addison 11
Atlanta 11
Augusta 10
São Paulo 10
Mountain View 9
Redmond 9
Tokyo 9
Bangkok 8
Brno 8
Chennai 8
Council Bluffs 8
San Mateo 8
Cairo 7
Guangzhou 7
Jinan 7
Rome 7
Bandung 6
Hounslow 6
Ningbo 6
Parma 6
Rimini 6
Rio de Janeiro 6
Songpa-gu 6
Auburn Hills 5
Bochum 5
Dearborn 5
Detroit 5
Kunming 5
Lappeenranta 5
Nicosia 5
Tappahannock 5
Vienna 5
Changchun 4
Florence 4
Kowloon City 4
Monmouth Junction 4
Orange 4
Perth 4
Pontianak 4
Senigallia 4
Surabaya 4
Sydney 4
Tanta 4
Tehran 4
Tel Aviv 4
Yogyakarta 4
Aveiro 3
Bari 3
Totale 6.757
Nome #
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology 308
Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): Rationale and design of a randomized clinical trial 271
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 229
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 200
Exercise Intervention to Improve Functional Capacity in Older Adults After Acute Coronary Syndrome 191
Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study) 170
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings 169
Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study 163
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 154
Prospective identification of stent fracture by enhanced stent visualization system during percutaneous coronary intervention 154
Uric acid and coronary artery disease: An elusive link deserving further attention 146
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 146
The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study 146
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 142
Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial 139
Fractional flow reserve: Current applications and overview of the available data 136
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 136
Fractional flow reserve evaluation and chronic kidney disease: Analysis from a multicenter Italian registry (the FREAK study) 134
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 133
Reperfusion Damage - A Story of Success, Failure, and Hope 133
Can we improve myocardial protection during ischaemic injury? 132
Ticagrelor improves endothelial function by decreasing circulating Epidermal Growth Factor (EGF) 129
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 127
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention 124
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials 123
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 123
Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients with ST-Segment-Elevation Myocardial Infarction and Multivessel Disease 122
Nutritional status and all-cause mortality in older adults with acute coronary syndrome 122
Bleeding Risk Scores and Scales of Frailty for the Prediction of Haemorrhagic Events in Older Adults with Acute Coronary Syndrome: Insights from the FRASER study 119
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study 116
Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry 115
Diagnostic accuracy of baseline troponin and troponin change for the diagnosis of myocardial infarction complicated with heart failure 112
BRS implantation in long lesions requiring device overlapping: Myth or reality? 112
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study 111
Fractional flow reserve implementation in daily clinical practice: A European survey 111
Role of the tricuspid regurgitation after mitraclip and transcatheter aortic valve implantation: A systematic review and meta-analysis 110
Same-day transfer for the invasive strategy of patients with non-ST-segment elevation acute coronary syndrome admitted to spoke hospitals: Data from the Emilia-Romagna Regional Network 105
The impact of the 3-year ABSORB II trial results on my clinical practice: An Italian survey 105
Dual Antiplatelet Therapy in Patients with Glucose-6-Phosphate Dehydrogenase Deficiency undergoing PCI with Drug-Eluting Stents. 104
Optical coherence tomography evaluation of overlapping everolimus-eluting bioresorbable vascular scaffold implantation guided by enhanced stent visualization system 102
Impact of postdilatation on performance of bioresorbable vascular scaffolds in patients with acute coronary syndrome compared with everolimus-eluting stents: A propensity score-matched analysis from a multicenter “real-world” registry 100
Transradial coronary catheterization and intervention across the whole spectrum of Allen test results 98
Right Ventricle Function in Patients with Acute Coronary Syndrome and Concomitant Undiagnosed Chronic Obstructive Pulmonary Disease 98
Overview of the pharmacological challenges facing physicians in the management of patients with concomitant cardiovascular disease and chronic obstructive pulmonary disease 96
Angina and left ventricular dysfunction: can we "reduce' it? 95
null 94
Adenosine-Free Indexes vs. Fractional Flow Reserve for Functional Assessment of Coronary Stenoses: Systematic Review and Meta-Analysis 93
Angina and chronic obstructive pulmonary disease: facing the perfect storm 93
Remodelling after an Infarct: Crosstalk between Life and Death 91
Seven french radial artery access for PCI: A prospective single-center experience 84
Short- Versus Long-Term Duration of Dual Antiplatelet Therapy in Patients Treated for In-Stent Restenosis: A PRODIGY Trial Substudy (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) 82
Relationship between physical activity and long-term outcomes in patients with stable coronary artery disease 80
Prognostic Value of QFR Measured Immediately After Successful Stent Implantation: The International Multicenter Prospective HAWKEYE Study 80
Enhanced stent visualization systems during PCI: A case series and review of literature 78
Short term outcome following acute phase switch among P2Y12 inhibitors in patients presenting with acute coronary syndrome treated with PCI: A systematic review and meta-analysis including 22,500 patients from 14 studies 74
Contrast Associated Acute Kidney Injury and Mortality in Older Adults with Acute Coronary Syndrome: A Pooled Analysis of the FRASER and HULK Studies 74
Meta-Analyses on DAPT Length: Chasing the Calm After the (Perfect) Storm 73
Angio-based index of microcirculatory resistance for the assessment of the coronary resistance: A proof of concept study 73
Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU (Gauging coronary Healing with bioresorbable Scaffolding plaTforms in EUrope) Registry 72
Functional Assessment and Acute Coronary Syndrome 72
Exercise intervention improves quality of life in older adults after myocardial infarction: randomised clinical trial 72
10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction 68
Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study 67
Safety and Feasibility of Transradial Mini-Invasive Balloon Aortic Valvuloplasty: A Pilot Study 66
Index of microcirculatory resistance assessment in patients with new diagnosis of left ventricular dilatation without significant coronary artery lesions: IMPAIRED pilot trial 66
Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials 63
Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure 61
Extracorporeal Circulatory Support in Acute Coronary Syndromes: A Systematic Review and Meta-Analysis 57
Impact of Absorb bioresorbable scaffold implantation technique on post-procedural quantitative coronary angiographic endpoints in ST-elevation myocardial infarction: a sub-analysis of the BVS STEMI STRATEGY-IT study 57
Lipid Plaque Burden in NSTE-ACS patients with or without COPD: insights from the SCAP trial 55
Angio-Based Fractional Flow Reserve, Functional Pattern of Coronary Artery Disease, and Prediction of Percutaneous Coronary Intervention Result: a Proof-of-Concept Study 51
Safety, efficacy and impact on frailty of mini-invasive radial balloon aortic valvuloplasty 51
One-Year Clinical Outcomes of Forty-Eight Millimeter Everolimus-Eluting Stent Implanted in Very Long Lesions: A Propensity-Matched Comparison (The FREIUS Study) 49
Acute myocardial infarction and large coronary thrombosis in a patient with COVID-19 45
Comparison of quantitative flow ratio, Pd/Pa and diastolic hyperemia-free ratio versus fractional flow reserve in non-culprit lesion of patients with non ST-segment elevation myocardial infarction 45
Age and Outcomes in TAVR Patients: Are We Barking Up the Wrong Tree? 43
Impact of trans-stent gradient on outcome after PCI: results from a HAWKEYE substudy 42
Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets 38
Effects of pre-hospital clopidogrel administration on early and late residual platelet reactivity in ST-segment elevation myocardial infarction patients undergoing primary intervention 36
Coronary Computed Tomography Angiography for the Assessment of Sirolimus-Eluting Resorbable Magnesium Scaffold 34
Acetylcholine Use in Modern Cardiac Catheterization Laboratories: A Systematic Review 33
Frailty in patients admitted to hospital for acute coronary syndrome: when, how and why? 33
Bioresorbable vascular scaffold overlap evaluation with optical coherence tomography after implantation with or without enhanced stent visualization system (WOLFIE study): a two-centre prospective comparison 33
Neural interfaces to monitor Interventional Cardiologists' mental workload: GAME-ON SAGA 33
Coronary Physiology Guidance vs. Conventional Angiography for Optimization of Percutaneous Coronary Intervention: the AQVA II Trial 32
QFR-Based Virtual PCI or Conventional Angiography to Guide PCI: The AQVA Trial 28
Comment on [Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease] 28
#FullPhysiology: a systematic step-by-step guide to implement intracoronary physiology in daily practice 27
What are the recommendations for adding novel oral anticoagulants to P2Y12-receptor inhibitors, with or without aspirin? 27
Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trial 27
Quantitative flow ratio as a new tool for angiography-based physiological evaluation of coronary artery disease: a review 27
Ten-year prognostic impact of target versus non-target vessel failure after STEMI. Insight from the EXAMINATION-EXTEND trial 26
Physiology-guided revascularization versus optimal medical therapy of nonculprit lesions in elderly patients with myocardial infarction: Rationale and design of the FIRE trial 26
CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY FOR THE ASSESSMENT OF SIROLIMUS-ELUTING RESORBABLE MAGNESIUM SCAFFOLD 25
Long-term outcomes of patients treated with sirolimus-eluting resorbable magnesium scaffolds: Insights from the SHERPA-MAGIC study 24
Clinical Outcome of FFR-Guided Revascularization Strategy of Coronary Lesions: The HALE-BOPP Study 23
Complete versus culprit-only strategy in older MI patients with multivessel disease 22
Shedding Light on Treatment Options for Coronary Vasomotor Disorders: A Systematic Review 22
Functional (Re)Development of SYNTAX Score II 2020: Predictive Performance and Risk Assessment 21
Functional assessment 3.0: From wire through angio to OCT 21
Totale 9.028
Categoria #
all - tutte 58.307
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.307


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020627 0 0 0 0 0 0 0 156 175 164 79 53
2020/20211.185 63 59 53 108 69 79 66 167 62 174 192 93
2021/20221.032 104 95 78 43 46 57 56 72 45 77 123 236
2022/2023870 104 55 49 69 126 119 68 72 120 8 58 22
2023/2024891 48 67 36 19 60 147 53 95 23 59 76 208
2024/20252.179 112 104 279 237 504 447 338 158 0 0 0 0
Totale 9.372